- Since 2026 : Biomaterials and Microfluidics (C2RT), Institut Pasteur, Paris.
- 2024-2025 : Immuno-oncology, Sanofi, Vitry-sur-Seine. In vitro evaluation of myeloid cells transfection using mRNA-LNP drug candidates
- 2024 : Oncology, Institute for Advanced Biosciences, Grenoble. Mechanisms of resistance to targeted therapies in melanoma: role of IGF1R/integrin interactions and identification of new therapeutic targets
- 2022 – 2023 : Bioanalysis, Sanofi, Vitry-sur-Seine. Optimization of capillary gel electrophoresis and size-exclusion chromatography methods for the characterization of monoclonal antibodies
Cliquez pour voir le graph
Connexions
